Dr. Kevin White serves as Chief Science Officer at Tempus. He is a pioneer in generating and analyzing large scale biological datasets to generate insights into complex biological systems. Since the 1990s White has contributed to the development of the fields of genomics and systems biology, and since the mid-2000s he has focused his efforts on developing new approaches for accelerating precision medicine through the analysis of large scale ‘omics and clinical data. His team’s work has led to a wide range of advances, from a deeper understanding of the evolutionary processes that shape the genome, to the discovery of novel cancer genes in a wide range of tumor types including breast cancer, kidney cancer, and myeloid leukemias. White received PhD and postdoctoral training at Stanford University where he developed the first functional genomics approaches for the study of complex developmental and evolutionary processes.  He subsequently focused his efforts on combining basic and translational research in the fields of genomics, computational science and systems biology as a faculty member at Yale University (2001-2006) and at the University of Chicago (2006-2019), where he was the James and Karen Frank Family Professor of Human Genetics and Medicine and Founding Director of the Institute for Genomics in Chicago. There he built a team of a dozen faculty and over 100 staff that won over $150M in research funding contracts and awards aimed at developing new approaches for using genomics, systems biology and computational science to accelerate development of novel diagnostics and therapeutics. In 2015 he began to help develop a new company, Tempus, with the vision of using genomics, computation and systems biology to enable every new patient to be treated with the benefit of the analysis of data from all of those who came before. He joined Tempus full time in early 2016. Prior to Tempus, his academic awards for innovation include the Keck Biomedical Investigator and Beckman Young Investigator awards, and he has also been recognized for his entrepreneurship on the ‘40 under 40’ list by Chicago Crain’s Business. White has served on the scientific boards of a wide range of start-up biotech companies and foundations. He also has previously served as founder and CEO of HealthSeq Pvt. Ltd. (now Tempus Singapore Pvt. Ltd.), providing hospitals with protected data clouds for analysis of genome and clinical records data. In the nonprofit sector he has held scientific advisory board positions at institutions that include Harvard University, Yale University, Northwestern University, and the National Cancer Institute. Dr. White has a B.S. and M.S. from Yale and a Ph.D. from Stanford University.